Like in gliomas and HBs, in AVMs, HPCs, meningiomas, metastatic carcinomas (Figure 6a), schwannomas, and SFTs, the nuclei of the endothelial cells lining vascular lumens demonstrated strong immunoreactivity for ERG (Figure 6b). Here, ERG is linked to metastatic carcinoma.